Cargando…
Understanding cell signaling in cancer stem cells for targeted therapy – can phosphoproteomics help to reveal the secrets?
BACKGROUND: Cancer represents heterogeneous and aberrantly proliferative manifestations composed of (epi)genetically and phenotypically distinct cells with a common clonal origin. Cancer stem cells (CSC) make up a rare subpopulation with the remarkable capacity to initiate, propagate and spread a ma...
Autores principales: | Gruber, Wolfgang, Scheidt, Tamara, Aberger, Fritz, Huber, Christian G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372284/ https://www.ncbi.nlm.nih.gov/pubmed/28356110 http://dx.doi.org/10.1186/s12964-017-0166-1 |
Ejemplares similares
-
Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cells
por: Scheidt, Tamara, et al.
Publicado: (2020) -
An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma
por: Gruber, Wolfgang, et al.
Publicado: (2014) -
Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion
por: Sacco, Francesca, et al.
Publicado: (2016) -
Systematic Synergy of Glucose and GLP-1 to Stimulate Insulin Secretion Revealed by Quantitative Phosphoproteomics
por: Tang, Jia-shu, et al.
Publicado: (2017) -
Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2021)